Suppr超能文献

相似文献

1
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
J Immunol. 2009 Feb 15;182(4):2102-12. doi: 10.4049/jimmunol.0802769.
3
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
J Immunol. 2007 Oct 15;179(8):5064-70. doi: 10.4049/jimmunol.179.8.5064.
5
The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
J Immunol. 2011 Aug 1;187(3):1097-105. doi: 10.4049/jimmunol.1003496. Epub 2011 Jun 22.
6
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
Blood. 2008 Sep 1;112(5):2149-55. doi: 10.1182/blood-2007-12-127449. Epub 2008 Jun 24.
7
Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
J Immunol. 2005 Dec 1;175(11):7372-9. doi: 10.4049/jimmunol.175.11.7372.
8
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Nat Immunol. 2009 Nov;10(11):1185-92. doi: 10.1038/ni.1790. Epub 2009 Sep 27.
9
Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
Cancer Immunol Immunother. 2011 Apr;60(4):547-58. doi: 10.1007/s00262-010-0963-5. Epub 2011 Jan 15.
10
Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
J Immunol. 2004 Oct 1;173(7):4324-30. doi: 10.4049/jimmunol.173.7.4324.

引用本文的文献

1
Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management.
Immunotherapy. 2025 Mar;17(4):293-303. doi: 10.1080/1750743X.2025.2473305. Epub 2025 Mar 7.
4
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.
Inflamm Res. 2024 Aug;73(8):1311-1332. doi: 10.1007/s00011-024-01900-w. Epub 2024 Jun 5.
6
Effects of and/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes.
Food Waterborne Parasitol. 2023 Jun 27;32:e00201. doi: 10.1016/j.fawpar.2023.e00201. eCollection 2023 Sep.
8
9
PD-1/PD-L1 and DNA Damage Response in Cancer.
Cells. 2023 Feb 7;12(4):530. doi: 10.3390/cells12040530.
10
Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
Cancers (Basel). 2023 Jan 20;15(3):657. doi: 10.3390/cancers15030657.

本文引用的文献

2
Deletional tolerance mediated by extrathymic Aire-expressing cells.
Science. 2008 Aug 8;321(5890):843-7. doi: 10.1126/science.1159407.
3
Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity.
Gastroenterology. 2008 Apr;134(4):1028-37. doi: 10.1053/j.gastro.2008.01.070. Epub 2008 Jan 30.
4
Celiac disease.
Am Fam Physician. 2007 Dec 15;76(12):1795-802.
5
PD-1 and its ligands in tolerance and immunity.
Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331.
6
Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
J Immunol. 2007 Dec 1;179(11):7466-77. doi: 10.4049/jimmunol.179.11.7466.
7
Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.
Circulation. 2007 Oct 30;116(18):2062-71. doi: 10.1161/CIRCULATIONAHA.107.709360. Epub 2007 Oct 15.
8
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
J Immunol. 2007 Oct 15;179(8):5064-70. doi: 10.4049/jimmunol.179.8.5064.
9
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
Immunity. 2007 Jul;27(1):111-22. doi: 10.1016/j.immuni.2007.05.016. Epub 2007 Jul 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验